1213 related articles for article (PubMed ID: 16914138)
21. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
[TBL] [Abstract][Full Text] [Related]
22. Nociception, antinociceptive potency of morphine in streptozotocin induced diabetic rats.
Mahajan AS; Chakrabarty K; Mishra TK; Chakrabarty AS
Indian J Physiol Pharmacol; 1997 Oct; 41(4):416-20. PubMed ID: 10235666
[TBL] [Abstract][Full Text] [Related]
23. Influence of low doses of naltrexone on morphine antinociception and morphine tolerance in male and female rats of four strains.
Terner JM; Barrett AC; Lomas LM; Negus SS; Picker MJ
Pain; 2006 May; 122(1-2):90-101. PubMed ID: 16527399
[TBL] [Abstract][Full Text] [Related]
24. Involvement of cholecystokinin in the opioid tolerance induced by dipyrone (metamizol) microinjections into the periaqueductal gray matter of rats.
Tortorici V; Nogueira L; Aponte Y; Vanegas H
Pain; 2004 Nov; 112(1-2):113-20. PubMed ID: 15494191
[TBL] [Abstract][Full Text] [Related]
25. Nefopam and ketoprofen synergy in rodent models of antinociception.
Girard P; Verniers D; Coppé MC; Pansart Y; Gillardin JM
Eur J Pharmacol; 2008 Apr; 584(2-3):263-71. PubMed ID: 18316069
[TBL] [Abstract][Full Text] [Related]
26. Stereoselective action of (+)-morphine over (-)-morphine in attenuating the (-)-morphine-produced antinociception via the naloxone-sensitive sigma receptor in the mouse.
Wu HE; Hong JS; Tseng LF
Eur J Pharmacol; 2007 Oct; 571(2-3):145-51. PubMed ID: 17617400
[TBL] [Abstract][Full Text] [Related]
27. The local antinociceptive actions of nonsteroidal antiinflammatory drugs in the mouse radiant heat tail-flick test.
Dogrul A; Gülmez SE; Deveci MS; Gul H; Ossipov MH; Porreca F; Tulunay FC
Anesth Analg; 2007 Apr; 104(4):927-35. PubMed ID: 17377109
[TBL] [Abstract][Full Text] [Related]
28. Increased analgesic potency of mu agonists after continuous naloxone infusion in rats.
Paronis CA; Holtzman SG
J Pharmacol Exp Ther; 1991 Nov; 259(2):582-9. PubMed ID: 1658305
[TBL] [Abstract][Full Text] [Related]
29. Effects of electrolytic lesion of dorsolateral periaqueductal gray on analgesic response of morphine microinjected into the nucleus cuneiformis in rat.
Haghparast A; Ahmad-Molaei L
Neurosci Lett; 2009 Feb; 451(2):165-9. PubMed ID: 19146915
[TBL] [Abstract][Full Text] [Related]
30. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat.
Fürst S; Riba P; Friedmann T; Tímar J; Al-Khrasani M; Obara I; Makuch W; Spetea M; Schütz J; Przewlocki R; Przewlocka B; Schmidhammer H
J Pharmacol Exp Ther; 2005 Feb; 312(2):609-18. PubMed ID: 15383636
[TBL] [Abstract][Full Text] [Related]
31. Opioid sensitivity of nucleus raphe magnus ater analgesia by nonsteroidal anti-inflammatory drugs.
Nozadze I; Tsiklauri N; Gurtskaia G; Abzianidze E; Tsagareli MG
Georgian Med News; 2011 Jan; (190):50-5. PubMed ID: 21346268
[TBL] [Abstract][Full Text] [Related]
32. Is endogenous opioid system involved in non-opioid analgesics tolerance?
Tsiklauri N; Gurtskaia G; Tsagareli M
Georgian Med News; 2006 Aug; (137):121-5. PubMed ID: 16980767
[TBL] [Abstract][Full Text] [Related]
33. Epidural ketamine potentiates epidural morphine but not fentanyl in acute nociception in rats.
Hoffmann VL; Baker AK; Vercauteren MP; Adriaensen HF; Meert TF
Eur J Pain; 2003; 7(2):121-30. PubMed ID: 12600793
[TBL] [Abstract][Full Text] [Related]
34. [A comprehensive study of the neurochemical and immune mechanisms of morphine tolerance: the effects of naloxone].
Litvinova SV; Shul'govskiĭ VV; Gruden' MA; Panchenko LF; Terebilina NN; Aristova VV; Kaliuzhnyĭ AL
Patol Fiziol Eksp Ter; 2000; (1):6-9. PubMed ID: 10741178
[TBL] [Abstract][Full Text] [Related]
35. Evidence for a peripheral mechanism of action for the potentiation of the antinociceptive effect of morphine by dipyrone.
Aguirre-Bañuelos P; Granados-Soto V
J Pharmacol Toxicol Methods; 1999 Oct; 42(2):79-85. PubMed ID: 10924890
[TBL] [Abstract][Full Text] [Related]
36. Potentiation of morphine antinociception by pentobarbital in female vs. male rats.
Craft RM; Leitl MD
Pain; 2006 Mar; 121(1-2):115-25. PubMed ID: 16473463
[TBL] [Abstract][Full Text] [Related]
37. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
38. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
39. Ultra-low dose naloxone restores the antinocicepitve effect of morphine in PTX-treated rats: association of IL-10 upregulation in the spinal cord.
Lin YS; Tsai RY; Shen CH; Chien CC; Tsai WY; Guo SL; Wong CS
Life Sci; 2012 Sep; 91(5-6):213-20. PubMed ID: 22820166
[TBL] [Abstract][Full Text] [Related]
40. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
